What are the recommended medications for treating panic attacks?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Medications for Panic Attacks

Selective Serotonin Reuptake Inhibitors (SSRIs) are the first-line pharmacological treatment for panic attacks due to their effectiveness, safety profile, and long-term efficacy. 1, 2

First-Line Medications

SSRIs

  • Preferred options: Sertraline, escitalopram, fluoxetine, fluvoxamine, paroxetine
  • Starting dose: 20 mg once daily for most SSRIs
  • Mechanism: Inhibit presynaptic reuptake of serotonin, increasing serotonin availability at synaptic cleft
  • Onset: Full therapeutic effect typically takes 4-6 weeks
  • Side effects: Dry mouth, nausea, diarrhea, headache, somnolence, insomnia, sexual dysfunction

SNRIs

  • Option: Venlafaxine
  • Efficacy: Comparable to SSRIs
  • Side effects: Similar to SSRIs plus more noradrenergic effects (increased blood pressure, sweating)

Second-Line Medications

Tricyclic Antidepressants (TCAs)

  • Options: Clomipramine, imipramine
  • Efficacy: As effective as SSRIs but less well tolerated 3
  • Limitations: Require cardiac monitoring in patients over 40 years
  • Side effects: Drowsiness, weight gain, anticholinergic symptoms

Short-Term/Adjunctive Medications

Benzodiazepines

  • Options: Alprazolam, clonazepam, diazepam
  • Use: Short-term treatment (1-4 weeks) for breakthrough anxiety during initiation of SSRIs 1, 4
  • Caution: Risk of dependence and tolerance; not recommended for long-term use
  • Evidence: Alprazolam has proven efficacy in placebo-controlled studies for panic disorder 4
  • Dosing: For alprazolam, doses up to 4 mg/day were used in clinical studies, though panic disorder often requires 5-6 mg/day 4

Treatment Algorithm

  1. Initial treatment:

    • Start with an SSRI (sertraline or escitalopram) at 20 mg/day
    • Consider adding a benzodiazepine (e.g., alprazolam) for the first 2-4 weeks only while waiting for SSRI effect
  2. After 4-6 weeks:

    • If good response: Continue SSRI for at least 24-28 weeks after initial response
    • If partial response: Increase SSRI dose within recommended range
    • If no response: Switch to another SSRI or an SNRI
  3. For treatment-resistant cases:

    • Consider TCA (clomipramine or imipramine)
    • Consider combination therapy with CBT

Important Considerations

Duration of Treatment

  • Continue treatment for at least 24-28 weeks after initial response
  • Gradual tapering essential when discontinuing medications to avoid withdrawal symptoms

Potential Pitfalls

  • Inadequate duration: Premature discontinuation increases relapse risk
  • Abrupt discontinuation: Can cause withdrawal symptoms, particularly with benzodiazepines and SSRIs
  • Overlooking comorbidities: Address concurrent depression or substance use disorders

Special Populations

  • Children/adolescents (6-18 years): SSRIs are recommended for anxiety disorders including panic disorder 5
  • Elderly patients: Use lower starting doses and slower titration
  • Hepatic/renal impairment: Use caution, particularly with paroxetine

Combination with Psychotherapy

  • Cognitive Behavioral Therapy (CBT) combined with medication is the most successful treatment strategy for panic disorder 6
  • CBT typically consists of 14 individual sessions over 4 months, each session lasting 60-90 minutes 1

The evidence strongly supports SSRIs as first-line treatment for panic attacks, with benzodiazepines reserved for short-term use only due to dependence risk, despite their rapid onset of action 7, 2.

References

Guideline

Anxiety Disorder Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Pharmacological treatments in panic disorder in adults: a network meta-analysis.

The Cochrane database of systematic reviews, 2023

Research

Management of panic disorder.

Expert review of neurotherapeutics, 2005

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Pharmacological treatment of panic disorder.

Modern trends in pharmacopsychiatry, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.